Race Oncology Limited (RAONF)
RAONF Stock Price Chart
Explore Race Oncology Limited interactive price chart. Choose custom timeframes to analyze RAONF price movements and trends.
RAONF Company Profile
Discover essential business fundamentals and corporate details for Race Oncology Limited (RAONF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Mar 2021
Employees
—
Website
https://www.raceoncology.comCEO
Daniel Tillett
Description
Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.
RAONF Financial Timeline
Browse a chronological timeline of Race Oncology Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Feb 2026
Earnings released on 21 Jul 2025
Earnings released on 26 Feb 2025
EPS came in at $0.00 , while revenue for the quarter reached $1.63M .
Earnings released on 20 Oct 2024
EPS came in at $0.00 , while revenue for the quarter reached $1.78M .
Earnings released on 27 Aug 2024
EPS came in at -$0.03 .
Earnings released on 17 Apr 2024
EPS came in at -$0.02 .
Earnings released on 27 Feb 2024
EPS came in at -$0.02 , while revenue for the quarter reached $1.36M .
Earnings released on 29 Jan 2024
EPS came in at -$0.01 , while revenue for the quarter reached $1.28M .
Earnings released on 30 Jun 2023
EPS came in at -$0.02 , while revenue for the quarter reached $1.20M .
Earnings released on 31 Mar 2023
EPS came in at -$0.01 , while revenue for the quarter reached $608.50K .
Earnings released on 31 Dec 2022
EPS came in at -$0.02 , while revenue for the quarter reached $903.45K .
Earnings released on 30 Sept 2022
EPS came in at -$0.01 , while revenue for the quarter reached $428.34K .
Earnings released on 30 Jun 2022
EPS came in at -$0.03 .
Earnings released on 31 Mar 2022
EPS came in at -$0.01 .
Earnings released on 31 Dec 2021
EPS came in at -$0.02 , while revenue for the quarter reached $513.04K .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 , while revenue for the quarter reached $256.10K , missing expectations by -98.03%.
Earnings released on 30 Jun 2021
EPS came in at -$0.02 .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $148.54K .
Earnings released on 30 Sept 2020
EPS came in at -$0.01 , while revenue for the quarter reached $138.79K .
RAONF Stock Performance
Access detailed RAONF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.